MYLAN 6727 MYLAN 6727 (Zonisamide 100 mg)
Pill imprint MYLAN 6727 MYLAN 6727 has been identified as Zonisamide 100 mg.
Zonisamide is used in the treatment of migraine prevention; seizures; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 6727 MYLAN 6727
- Strength:
- 100 mg
- Color:
- Purple / Blue
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-6727
- Inactive Ingredients:
- lactose anhydrous
ferrosoferric oxide
silicon dioxide
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
microcrystalline cellulose
propylene glycol
shellac
sodium lauryl sulfate
titanium dioxide
FD&C Red No. 3
gelatin
magnesium stearate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0768 | UDL Laboratories Inc |
| 16590-0539 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
More about zonisamide
Consumer resources
- Other brands: Zonegran
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
